Petree Daniel H 4

4 · SUTRO BIOPHARMA, INC. · Filed Feb 9, 2022

Form 4

Period: 2022-02-08

Director

Transactions

Exercise/Conversion
Common Stock
2022-02-08$5.81/sh+873$5,072→ 16,601 total
Exercise/Conversion
Stock Option (right to buy)
2022-02-08−2,617→ 0 total
Exercise: $4.36Exp: 2022-09-19→ Common Stock (2,617 underlying)
Exercise/Conversion
Stock Option
2022-02-08−2,124→ 0 total
Exercise: $5.81Exp: 2024-02-26→ Common Stock (2,124 underlying)
Exercise/Conversion
Stock Option (right to buy)
2022-02-08−4,545→ 0 total
Exercise: $4.36Exp: 2022-04-17→ Common Stock (4,545 underlying)
Exercise/Conversion
Stock Option (right to buy)
2022-02-08−578→ 0 total
Exercise: $5.81Exp: 2023-02-13→ Common Stock (578 underlying)
Exercise/Conversion
Common Stock
2022-02-08$4.36/sh+4,545$19,816→ 12,533 total
Exercise/Conversion
Common Stock
2022-02-08$4.36/sh+2,617$11,410→ 15,150 total
Exercise/Conversion
Common Stock
2022-02-08$5.81/sh+2,124$12,340→ 18,725 total
Exercise/Conversion
Common Stock
2022-02-08$5.81/sh+578$3,358→ 15,728 total
Exercise/Conversion
Common Stock
2022-02-08$5.81/sh+3,540$20,567→ 22,265 total
Exercise/Conversion
Stock Option (right to buy)
2022-02-08−873→ 0 total
Exercise: $5.81Exp: 2023-02-13→ Common Stock (873 underlying)
Exercise/Conversion
Stock Option
2022-02-08−3,540→ 0 total
Exercise: $5.81Exp: 2024-02-26→ Common Stock (3,540 underlying)

Holdings

Footnotes (2)

[F1]These securities are held of record by the reporting person and his spouse as trustees of the Daniel H. Petree and Susan M. Toeniskoetter Trust dated July 25, 1997.
[F2]The option is fully vested and exercisable.

Documents

1 file